April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
TMCO1 is associated with POAG in the Ocular Hypertension Treatment Study (OHTS)
Author Affiliations & Notes
  • John H Fingert
    Ophthalmology, Carver College of Medicine, University of Iowa, Iowa City, IA
    Stephen A. Wynn Institute for Vision Research, University of Iowa, Iowa City, IA
  • Kai Wang
    Stephen A. Wynn Institute for Vision Research, University of Iowa, Iowa City, IA
    Biostatistics, College of Public Health, University of Iowa, Iowa City, IA
  • Ben Faga
    College of Engineering, University of Iowa, Iowa City, IA
  • Lizette Ortega
    Biostatistics, College of Public Health, University of Iowa, Iowa City, IA
  • Mae O Gordon
    Ophthalmology, School of Medicine, Washington University, St. Louis, MO
  • Michael A Kass
    Ophthalmology, School of Medicine, Washington University, St. Louis, MO
  • Todd Scheetz
    Ophthalmology, Carver College of Medicine, University of Iowa, Iowa City, IA
    Stephen A. Wynn Institute for Vision Research, University of Iowa, Iowa City, IA
  • Footnotes
    Commercial Relationships John Fingert, None; Kai Wang, None; Ben Faga, None; Lizette Ortega, None; Mae Gordon, None; Michael Kass, None; Todd Scheetz, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 2145. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      John H Fingert, Kai Wang, Ben Faga, Lizette Ortega, Mae O Gordon, Michael A Kass, Todd Scheetz; TMCO1 is associated with POAG in the Ocular Hypertension Treatment Study (OHTS). Invest. Ophthalmol. Vis. Sci. 2014;55(13):2145. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To determine if previously detected genetic risk factors are associated with developing POAG in participants in the Ocular Hypertension Treatment Study (OHTS).

Methods: OHTS participants had ocular hypertension and no clinical evidence of glaucoma at baseline. DNA and genotypes were available from 1057 OHTS participants. Of these, 209 developed POAG (cases) and 848 did not (controls) over 14 year follow-up. The allele frequencies of 14 previously discovered glaucoma risk alleles were compared between cases and controls using ANOVA. Secondary analyses examined allele frequency and POAG risk in self-reported non-Hispanic whites (70.7%) and self-reported blacks (23.7%). Kaplan-Meier and Cox proportional hazards analyses were used to determine if participants with POAG risk alleles were at higher risk of developing glaucoma those with no POAG risk alleles.

Results: No association between known risk alleles and POAG were detected in the analysis of all 1057 participants in the OHTS. However, the allele frequencies of the risk factors (the TMCO1 locus) were statistically different between the non-Hispanic white cases and controls, p = 0.00028 (significant with multiple measures corrections for analysis of 14 genes). Kaplan-Meier analysis, showed that non-Hispanic white participants in the OHTS who have 1 or 2 TMCO1 risk alleles were at higher risk of developing POAG than those with no risk alleles (~10% more glaucoma at 14 years, log rank p = 0.0014).

Conclusions: While the size of the OHTS cohort may limit its power to detect some of the known glaucoma risk factors, our analysis demonstrates that the TMCO1 genotype contributes a detectable increase in the risk of developing glaucoma in the largest subgroup of the OHTS cohort (non-Hispanic whites).

Keywords: 539 genetics • 464 clinical (human) or epidemiologic studies: risk factor assessment • 629 optic nerve  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×